Page last updated: 2024-10-27

fluoxetine and Metaplasia

fluoxetine has been researched along with Metaplasia in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Metaplasia: A condition in which there is a change of one adult cell type to another similar adult cell type.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saponara, E1
Visentin, M1
Baschieri, F1
Seleznik, G1
Martinelli, P1
Esposito, I1
Buschmann, J1
Chen, R1
Parrotta, R1
Borgeaud, N1
Bombardo, M1
Malagola, E1
Caflisch, A1
Farhan, H1
Graf, R1
Sonda, S1

Other Studies

1 other study available for fluoxetine and Metaplasia

ArticleYear
Serotonin uptake is required for Rac1 activation in Kras-induced acinar-to-ductal metaplasia in the pancreas.
    The Journal of pathology, 2018, Volume: 246, Issue:3

    Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Cell Transdifferentiati

2018